FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes

PMA: P850089 · Supplement: S167 · Decision Jul 1, 2024
Classifications
1
FEI Numbers
26
Registration Numbers
26

Basic Information

Device Name
Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes
Trade Name
CapSure SP Z Lead
PMA Number
P850089
Supplement Number
S167
Device Class
FDA Class 3
Product Code
NVN
Generic Name
Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
July 1, 2024
Date Received
June 3, 2024
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

an alternate manufacturing method at a supplier

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NVN Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes